CLINICAL_TRIALS
trial_result
· 2023-07-10
Clinical Trial Update: Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia [Phase 1, Phase 2]
Summary
Clinical trial update on safety, tolerability, and efficacy of Uproleselan (GMI-1271) in COVID-19 pneumonia, terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lena Napolitano, MD | Conditions: COVID-19 Pneumonia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-07-10